Patient characteristics (n = 18) at time of diagnosis and after disease control
| Time of diagnosis | |
| Age (years) | 50 (32; 74) |
| Sex (M/F) | 9/9 |
| Adenoma size (n) | |
| Macro | 16 |
| Micro | 2 |
| Disease control | |
| Time since intervention (weeks) | 47 (16; 163) |
| Pituitary surgery (y/n) | 14/4 |
| Somatostatin analogue (y/n) | 10/8 |
| GH-receptor antagonist (y/n) | 3/15 |
| Radiation therapy (y/n) | 0/18 |
| Dopamine agonist (y/n) | 2/16 |
| Diabetes mellitus (y/n) | 0/18 |
| Anterior pituitary deficiency (y/n) | 4/14 |
| Time of diagnosis | |
| Age (years) | 50 (32; 74) |
| Sex (M/F) | 9/9 |
| Adenoma size (n) | |
| Macro | 16 |
| Micro | 2 |
| Disease control | |
| Time since intervention (weeks) | 47 (16; 163) |
| Pituitary surgery (y/n) | 14/4 |
| Somatostatin analogue (y/n) | 10/8 |
| GH-receptor antagonist (y/n) | 3/15 |
| Radiation therapy (y/n) | 0/18 |
| Dopamine agonist (y/n) | 2/16 |
| Diabetes mellitus (y/n) | 0/18 |
| Anterior pituitary deficiency (y/n) | 4/14 |
Age and times since intervention are presented as mean (range).
Abbreviations: GH, growth hormone.
Patient characteristics (n = 18) at time of diagnosis and after disease control
| Time of diagnosis | |
| Age (years) | 50 (32; 74) |
| Sex (M/F) | 9/9 |
| Adenoma size (n) | |
| Macro | 16 |
| Micro | 2 |
| Disease control | |
| Time since intervention (weeks) | 47 (16; 163) |
| Pituitary surgery (y/n) | 14/4 |
| Somatostatin analogue (y/n) | 10/8 |
| GH-receptor antagonist (y/n) | 3/15 |
| Radiation therapy (y/n) | 0/18 |
| Dopamine agonist (y/n) | 2/16 |
| Diabetes mellitus (y/n) | 0/18 |
| Anterior pituitary deficiency (y/n) | 4/14 |
| Time of diagnosis | |
| Age (years) | 50 (32; 74) |
| Sex (M/F) | 9/9 |
| Adenoma size (n) | |
| Macro | 16 |
| Micro | 2 |
| Disease control | |
| Time since intervention (weeks) | 47 (16; 163) |
| Pituitary surgery (y/n) | 14/4 |
| Somatostatin analogue (y/n) | 10/8 |
| GH-receptor antagonist (y/n) | 3/15 |
| Radiation therapy (y/n) | 0/18 |
| Dopamine agonist (y/n) | 2/16 |
| Diabetes mellitus (y/n) | 0/18 |
| Anterior pituitary deficiency (y/n) | 4/14 |
Age and times since intervention are presented as mean (range).
Abbreviations: GH, growth hormone.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
